Researchers from The Augusta University says born babies are at high risk of acquiring diabetes, cardiovascular disease (CVD) and obesity from mothers who acquired gestational diabetes during pregnancy due to poor diet, smoking and high sugar levels. As incidents type 2 diabetes (T2D) and hypertension in children on the rise, National Institute of Child Health and Human Development awarded one million dollars "Pathway to Independence Award" to Dr. Jennifer Thompson, a postdoctoral fellow at Augusta University to study the effects of mothers gestational diabetes on children. The objective of the study was to find out markers for the Gestational Diabetes (GD) development in mothers during pregnancy so that mothers and physicians can take precautions and intervene.
Most of the babies of diabetes pregnant women have a higher risk of birth defects even though pregnant women control sugar levels during pregnancy time. This may be because babies are exposed to high sugar levels between fertilization and becoming fetus (called as embryonic development stage). Researchers at Joslin Diabetes Center found that glucosamine plays, another sugar that circulates in the blood, plays an important role during the embryonic development stage. Researchers found a gene called GLUT2 which transport glucose from the blood to cell efficiently if sugar levels are high. Now they are studying the role of glucosamine and GLUT2 during the embryonic development stage. Glucosamine tablets are prescribed for joint pain and not for pregnant women as effects of glucosamine not understood fully. The study results were published in the Scientific Reports.
A study done by the researchers from Tufts University shows that daily butter consumption has no association with total mortality, cardiovascular diseases (CVD) and diabetes. U.S. Department of Agriculture recommends 14 grams of butter (one tablespoon) consumption per day. Researchers conducted a study with 636,151 individuals in groups with an average consumption of butter ranging from one-third of serving to 3.2 servings per day and recorded deaths, new diabetes cases and cardiovascular disease (CVD). The analysis shows that small association between butter consumption with total mortality or new diabetes cases or CVD. The study indicates that butter is more healthful choice and slightly protective against type ii diabetes (T2D). Even though butter is high in saturated fats, researchers say a combination of nutrients in a food such as butter has a different effect on individuals health compared with single nutrient. But butter is the worst choice for cooking compared with oils containing unsaturated fats. The study findings were published in the PLOS One.
Joseph Aloi MD, Wake Forest Baptist Medical Center, North Carolina says less incidence of hypoglycemic events and lower average blood glucose can be achieved with the usage of the Glytec electronic glycemic management system (eGMS). He says hospitals can achieve glycemic targets of individual patients easily with the usage of eGMS compared with usual care. Glytec eGMS supports individual medication of insulin dose by calculating individual blood sugar levels considering other factors. The product prevents dangers associated with hypoglycemia and hyperglycemia and brings patients quickly and effectively within targeted blood glucose levels. Existing medical care in the hospitals shows the prevalence of hypoglycemia and hyperglycemia in hospitals are on the rise. Hypoglycemia and hyperglycemia conditions lead to higher medical costs, longer treatment time and stay.
Geneticist Dr. Jack Juvik and his team from the University of Illinois identified genes that help the body in the accumulation of phenolic compounds in broccoli. Consumption of food containing phenolic compounds lowers risks for type 2 diabetes (T2D), coronary heart diseases, asthma and some types of cancer. Now researchers are trying to use identified genes in breeding other vegetables to improve health benefits without altering physical characteristics of the vegetable and taste. The study results were published in Molecular Breeding.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.